Gapping up
In reaction to strong earnings/guidance:
- IMGN +20.1%, CGC +19.4%, EXPE +11.8%, ROKU +10%, AMN +9.5%, SVMK +8.1%, DXCM +7.5%, NVDA +6.5%, CC +6.1%, GDDY +5.8%, VECO +4.5%, TNET +4.3%, NET +3.8%, EBAY +2.4% (guides Q1, FY2020 following the sale of StubHub), FNF +2.1%, BKI +1.6%, BL +1.5%, MAT +1.1%, MHK +1%, CGNX +1%, RSG +0.9%, NWL +0.9%, AYX +0.8%, DLPH +0.7%
Other news:
- EPZM +4% (announces FDA acceptance of new drug application for filing with priority review for tazverik for the treatment of follicular lymphoma)
- RIG +1.7% (provides quarterly fleet status report; added approximately $366 mln in contract backlog, bringing total backlog to $10.2 bln)
Analyst comments:
- FTSI +5.4% (upgraded to Buy from Hold at Stifel)
- MTW +2.5% (upgraded to Neutral from Sell at Citigroup)
- ZBRA +1.8% (upgraded to Overweight from Neutral at JP Morgan)
- BL +1.5% (upgraded to Overweight from Neutral at Piper Sandler)